Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant
NCT06327308Phase 1Recruiting
- Sponsor
- CHU de Besançon
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by CHU de Besançon. Primary endpoint: Evolution of the percentage of myocardial fibrosis on cardiac MRI at 21 months. Started Mar 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06327308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06327308.